このページの翻訳は実験的なもので、現在開発中です。お待ちしております！
Elevance Health マネジメント
マネジメント 基準チェック /34
Elevance Health'sの CEO はGail Boudreauxで、 Nov2017年に任命され、 の在任期間は 6.58年です。 の年間総報酬は$ 21.89Mで、 7.3%給与と92.7%のボーナス（会社の株式とオプションを含む）で構成されています。 は、会社の株式の0.062%を直接所有しており、その価値は$ 76.95M 。経営陣と取締役会の平均在任期間はそれぞれ6.2年と10.8年です。
主要情報
Gail Boudreaux
最高経営責任者
US$21.9m
報酬総額
| CEO給与比率 | 7.3% |
| CEO在任期間 | 6.6yrs |
| CEOの所有権 | 0.06% |
| 経営陣の平均在職期間 | 6.2yrs |
| 取締役会の平均在任期間 | 10.8yrs |
経営陣の近況
Recent updates
Is Now An Opportune Moment To Examine Elevance Health, Inc. (NYSE:ELV)?
Jun 11
Elevance Health's (NYSE:ELV) Returns On Capital Are Heading Higher
May 27We Think Shareholders Will Probably Be Generous With Elevance Health, Inc.'s (NYSE:ELV) CEO Compensation
May 09Elevance Health (NYSE:ELV) Has Announced A Dividend Of $1.63
Apr 25Elevance Health: It's Not Too Late To Buy Their Dividend Growth
Apr 23Is Elevance Health (NYSE:ELV) Using Too Much Debt?
Apr 16Elevance Health: Not Doing Enough In 2024 To Justify Premium Price
Apr 11Elevance Health, Inc.'s (NYSE:ELV) Earnings Haven't Escaped The Attention Of Investors
Apr 01Elevance: A Healthy Dose Of Dividend Growth
Mar 21Elevance Heath: Financial Growth And Technical Strength Indicate A Buy
Mar 07Elevance Health (NYSE:ELV) Will Pay A Larger Dividend Than Last Year At $1.63
Feb 19Elevance Health: Time To Buy This Incredible Dividend Growth Stock
Jan 26Slowing Rates Of Return At Elevance Health (NYSE:ELV) Leave Little Room For Excitement
Jan 19Is Elevance Health (NYSE:ELV) A Risky Investment?
Jan 02Elevance Health, Inc.'s (NYSE:ELV) Shares Not Telling The Full Story
Dec 18A Look At Elevance's Margin Dynamics
Nov 23Is It Time To Consider Buying Elevance Health, Inc. (NYSE:ELV)?
Nov 16Elevance Health: A High Conviction Defensive Blue Chip Buy
Oct 19These 4 Measures Indicate That Elevance Health (NYSE:ELV) Is Using Debt Safely
Oct 04Elevance: Pave The Way For The Next UnitedHealth
Sep 21Elevance Health (NYSE:ELV) Is Experiencing Growth In Returns On Capital
Sep 18Here's The Price I Would Buy Elevance Health Stock
Sep 13If EPS Growth Is Important To You, Elevance Health (NYSE:ELV) Presents An Opportunity
Aug 18Is Now The Time To Look At Buying Elevance Health, Inc. (NYSE:ELV)?
Aug 04Narrowing Down High-Quality Dividend Growth: Elevance Health Is Elemental
Jul 24Elevance Health: Beaten Down Share Price Offers Solid Potential
Jul 10Here's Why Elevance Health (NYSE:ELV) Can Manage Its Debt Responsibly
Jul 05Elevance Health: A Critical Update (Rating Downgrade)
Jun 05Elevance Health's (NYSE:ELV) Returns On Capital Are Heading Higher
Jun 04Is Now The Time To Look At Buying Elevance Health, Inc. (NYSE:ELV)?
May 05We Think Elevance Health (NYSE:ELV) Can Stay On Top Of Its Debt
Apr 04Elevance Health's (NYSE:ELV) Dividend Will Be Increased To $1.48
Feb 17Elevance Health (NYSE:ELV) Is Experiencing Growth In Returns On Capital
Feb 13Elevance Health: Attractive On Its Expansion Catalysts
Feb 09Elevance Health (NYSE:ELV) Has Announced That It Will Be Increasing Its Dividend To $1.48
Jan 28Elevance Health acquiring Blue Cross and Blue Shield of Louisiana
Jan 23Elevance Health Offers Great Value
Jan 17At US$483, Is Elevance Health Inc. (NYSE:ELV) Worth Looking At Closely?
Jan 17Elevance Health: Strong And Steady EPS Growth Ahead, High Relative Strength Name
Jan 02Elevance Health (NYSE:ELV) Seems To Use Debt Rather Sparingly
Nov 28Does Elevance Health (NYSE:ELV) Deserve A Spot On Your Watchlist?
Nov 16Elevance Health to acquire speciality pharmacy from CarepathRx
Nov 09Elevance Health (NYSE:ELV) Is Doing The Right Things To Multiply Its Share Price
Nov 02Elevance Health declares $1.28 dividend
Oct 19Are Investors Undervaluing Elevance Health Inc. (NYSE:ELV) By 37%?
Oct 12Elevance affiliates to offer affordable Medicare Advantage plans
Oct 10Molina, Elevance, Centene win Medicare contracts in California
Aug 26CEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | US$6b |
| Dec 31 2023 | US$22m | US$2m | US$6b |
| Sep 30 2023 | n/a | n/a | US$6b |
| Jun 30 2023 | n/a | n/a | US$6b |
| Mar 31 2023 | n/a | n/a | US$6b |
| Dec 31 2022 | US$21m | US$2m | US$6b |
| Sep 30 2022 | n/a | n/a | US$6b |
| Jun 30 2022 | n/a | n/a | US$6b |
| Mar 31 2022 | n/a | n/a | US$6b |
| Dec 31 2021 | US$19m | US$2m | US$6b |
| Sep 30 2021 | n/a | n/a | US$6b |
| Jun 30 2021 | n/a | n/a | US$4b |
| Mar 31 2021 | n/a | n/a | US$5b |
| Dec 31 2020 | US$17m | US$1m | US$5b |
| Sep 30 2020 | n/a | n/a | US$5b |
| Jun 30 2020 | n/a | n/a | US$6b |
| Mar 31 2020 | n/a | n/a | US$5b |
| Dec 31 2019 | US$15m | US$1m | US$5b |
| Sep 30 2019 | n/a | n/a | US$4b |
| Jun 30 2019 | n/a | n/a | US$4b |
| Mar 31 2019 | n/a | n/a | US$4b |
| Dec 31 2018 | US$14m | US$1m | US$4b |
| Sep 30 2018 | n/a | n/a | US$5b |
| Jun 30 2018 | n/a | n/a | US$4b |
| Mar 31 2018 | n/a | n/a | US$4b |
| Dec 31 2017 | US$3m | US$162k | US$4b |
報酬と市場: Gailの 総報酬 ($USD 21.89M ) は、 US市場 ($USD 13.52M ) の同規模の企業の平均を上回っています。
報酬と収益: Gailの報酬は、過去 1 年間の会社の業績と一致しています。
CEO（最高経営責任者
Gail Boudreaux (63 yo)
6.6yrs
在職期間
US$21,889,039
報酬
Ms. Gail Koziara Boudreaux has been an Independent Director at Target Corporation since September 23, 2021. She has been President, Chief Executive Officer and Director of Elevance Health Inc. (formerly kn...
リーダーシップ・チーム
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| President | 6.6yrs | US$21.89m | 0.062% $ 75.9m | |
| Executive VP & CFO | less than a year | US$12.36m | データなし | |
| EVP, Chief Legal & Administrative Officer | 3.6yrs | US$8.11m | 0.0044% $ 5.4m | |
| Executive VP and President of Carelon & CarelonRx | 10yrs | US$6.98m | 0.0063% $ 7.7m | |
| Executive VP & President of Government Health Benefits | 6yrs | US$6.48m | 0.0097% $ 11.9m | |
| SVP, Treasurer & Chief Investment Officer | 6.2yrs | データなし | データなし | |
| Senior VP | 8.6yrs | データなし | 0.00057% $ 698.6k | |
| Chief Information Officer | no data | データなし | データなし | |
| Vice President of Investor Relations | no data | データなし | データなし | |
| Senior Vice President of Public Affairs | 10.6yrs | データなし | データなし | |
| Chief Strategy Officer & Interim Chief Marketing Officer | less than a year | データなし | データなし | |
| Executive VP and President of Commercial & Specialty Health Benefits | no data | データなし | 0.0050% $ 6.1m |
6.2yrs
平均在職期間
58yo
平均年齢
経験豊富な経営陣: ELVの経営陣は経験豊富で経験豊富です（平均在職期間は6.2年）。
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| President | 6.6yrs | US$21.89m | 0.062% $ 75.9m | |
| Independent Director | 19.6yrs | US$386.76k | 0.0027% $ 3.3m | |
| Independent Chair of the Board | 10.7yrs | US$597.83k | 0% $ 0 | |
| Independent Director | 10.9yrs | US$362.53k | 0% $ 0 | |
| Independent Director | 6.3yrs | US$371.42k | 0% $ 0 | |
| Independent Director | 10.1yrs | US$371.42k | 0% $ 0 | |
| Independent Director | 4.7yrs | US$347.28k | 0.0013% $ 1.6m | |
| Independent Director | 12.9yrs | US$360.34k | 0.0029% $ 3.6m | |
| Member of Advisory Board | 10.8yrs | データなし | データなし | |
| Member of Advisory Board | 10.8yrs | データなし | データなし | |
| Member of Advisory Board | 10.8yrs | データなし | データなし | |
| Member of Advisory Board | 10.8yrs | データなし | データなし |
10.8yrs
平均在職期間
68yo
平均年齢
経験豊富なボード: ELVの 取締役会 は経験豊富で 経験豊富 です ( 10.8年の平均在任期間)。